Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancers

Baykara, Meltem; Buyukberber, Suleyman; Ozturk, Banu; Coskun, UĞUR; Kaplan, Muhammet; Unsal, Diclehan; Dane, Faysal; Demirci, Umut; BORA, HÜSEYİN; Benekli, Mustafa

doi:10.1700/1361.15096

Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancers

Copy For Citation

Baykara M., Buyukberber S., Ozturk B., Coskun U., Kaplan M. A., Unsal D. K., ...More

TUMORI, vol.99, no.4, pp.469-473, 2013 (SCI-Expanded)

Publication Type: Article / Article
Volume: 99 Issue: 4
Publication Date: 2013
Doi Number: 10.1700/1361.15096
Journal Name: TUMORI
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.469-473
Gazi University Affiliated: Yes

Abstract

Aims and background. Chemoradiation using cisplatin-based regimens has become the standard care in the treatment of nasopharyngeal cancers, The impact of taxanes as radiosensitizing agents with concurrent chemoradiation regimens is unknown. We retrospectively evaluated the efficacy and tolerability of weekly cisplatin + docetaxel combination with chemoradiation in locally advanced nasopharyngeal cancers.